CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,556 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02564120
NCT02564120N/ACompleted

North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)

UNC Lineberger Comprehensive Cancer Center·observational·Posted Sep 30, 2015·Updated Apr 28, 2020

In Brief

An observational study for Cancer of Prostate and 3 related conditions. Completed, enrolled 1,556 participants across 1 site.

Detailed Summary

NC ProCESS is a cohort of patients from diverse backgrounds diagnosed with early prostate cancer, who were enrolled from January 2011-June 2013. These patients were recruited throughout North Carolina, and also in partnership with institutions across the country. Patients enrolled before they start treatment, and are then followed prospectively through treatment and then afterwards. This observational study collects information on quality of life, cancer control, and health care received inclusive of treatment and management of subsequent effects including complications and recurrence. The objective of this study is to examine comparative outcomes among different modern prostate cancer treatment options in this cohort of patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 30, 2015
Enrollment StartJan 1, 2011
Primary CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 8 yearsPosted 10.8 years ago